Renal Ablations

Ryan L. Steinberg; Jeffrey A. Cadeddu

doi:10.1007/978-3-030-73565-4_24

Renal Ablations

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Management of renal cell carcinoma has undergone a paradigm shift over the last two decades with a focus on nephron sparing. Simultaneously, the incidence of localized renal cell carcinoma (RCC) has dramatically increased due to the greater use and refinement of modern cross-sectional imaging. Initially considered experimental in nonsurgical patients, renal tumor ablation has burgeoned into an accepted treatment modality for patients with small renal masses. Renal ablation carries a number of advantages over extirpative surgery including being less technically demanding, reduced blood loss, lower rates of complications, improved renal function preservation, and faster post-procedure convalescence. In this chapter, we aim to describe the available ablative technologies and patient outcomes from each type of treatment.

Original language	English (US)
Title of host publication	Interventional Urology, Second Edition
Publisher	Springer International Publishing
Pages	377-396
Number of pages	20
ISBN (Electronic)	9783030735654
ISBN (Print)	9783030735647
DOIs	https://doi.org/10.1007/978-3-030-73565-4_24
State	Published - Jan 1 2021

Keywords

Ablative technologies
Cryoablation
Electroporation
Microwave ablation
Radiofrequency ablation
Renal ablation
Renal neoplasm
Small renal mass

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-73565-4_24

Cite this

@inbook{21330ccdc533417091aaf04b79aec2ba,

title = "Renal Ablations",

abstract = "Management of renal cell carcinoma has undergone a paradigm shift over the last two decades with a focus on nephron sparing. Simultaneously, the incidence of localized renal cell carcinoma (RCC) has dramatically increased due to the greater use and refinement of modern cross-sectional imaging. Initially considered experimental in nonsurgical patients, renal tumor ablation has burgeoned into an accepted treatment modality for patients with small renal masses. Renal ablation carries a number of advantages over extirpative surgery including being less technically demanding, reduced blood loss, lower rates of complications, improved renal function preservation, and faster post-procedure convalescence. In this chapter, we aim to describe the available ablative technologies and patient outcomes from each type of treatment.",

keywords = "Ablative technologies, Cryoablation, Electroporation, Microwave ablation, Radiofrequency ablation, Renal ablation, Renal neoplasm, Small renal mass",

author = "Steinberg, {Ryan L.} and Cadeddu, {Jeffrey A.}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-73565-4_24",

language = "English (US)",

isbn = "9783030735647",

pages = "377--396",

booktitle = "Interventional Urology, Second Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Renal Ablations

AU - Steinberg, Ryan L.

AU - Cadeddu, Jeffrey A.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Management of renal cell carcinoma has undergone a paradigm shift over the last two decades with a focus on nephron sparing. Simultaneously, the incidence of localized renal cell carcinoma (RCC) has dramatically increased due to the greater use and refinement of modern cross-sectional imaging. Initially considered experimental in nonsurgical patients, renal tumor ablation has burgeoned into an accepted treatment modality for patients with small renal masses. Renal ablation carries a number of advantages over extirpative surgery including being less technically demanding, reduced blood loss, lower rates of complications, improved renal function preservation, and faster post-procedure convalescence. In this chapter, we aim to describe the available ablative technologies and patient outcomes from each type of treatment.

AB - Management of renal cell carcinoma has undergone a paradigm shift over the last two decades with a focus on nephron sparing. Simultaneously, the incidence of localized renal cell carcinoma (RCC) has dramatically increased due to the greater use and refinement of modern cross-sectional imaging. Initially considered experimental in nonsurgical patients, renal tumor ablation has burgeoned into an accepted treatment modality for patients with small renal masses. Renal ablation carries a number of advantages over extirpative surgery including being less technically demanding, reduced blood loss, lower rates of complications, improved renal function preservation, and faster post-procedure convalescence. In this chapter, we aim to describe the available ablative technologies and patient outcomes from each type of treatment.

KW - Ablative technologies

KW - Cryoablation

KW - Electroporation

KW - Microwave ablation

KW - Radiofrequency ablation

KW - Renal ablation

KW - Renal neoplasm

KW - Small renal mass

UR - http://www.scopus.com/inward/record.url?scp=85160718573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160718573&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-73565-4_24

DO - 10.1007/978-3-030-73565-4_24

M3 - Chapter

AN - SCOPUS:85160718573

SN - 9783030735647

SP - 377

EP - 396

BT - Interventional Urology, Second Edition

PB - Springer International Publishing

ER -

Renal Ablations

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this